MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Clinical trial NCT02669914 · TERMINATED
Trial details
- NCT number
- NCT02669914
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-12
- Primary completion
- 2017-09-21
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.